Treatment failure Feeding interruption, blocking or leakage of the tube, non‐adherence · adult patients with swallowing disturbances
Percutaneous endoscopic gastrostomy may leads to lower treatment failure Feeding interruption, blocking or leakage of the… compared with nasogastric tube feeding (low certainty).
1 finding from 1 review
Mortality irrespective of · adult patients with swallowing disturbances
It is very uncertain whether percutaneous endoscopic gastrostomy changes mortality irrespective of compared with nasogastric tube feeding (very low certainty).
1 finding from 1 review
Pneumonia · adult patients with swallowing disturbances
Percutaneous endoscopic gastrostomy showed no clear difference in pneumonia irrespective of compared with nasogastric tube feeding (low certainty).
1 finding from 1 review
Adverse events irrespective of · adult patients with swallowing disturbances
Percutaneous endoscopic gastrostomy showed no clear difference in adverse events irrespective of compared with nasogastric tube feeding (moderate certainty).
1 finding from 1 review
Normalcy of diet (percutaneous endoscopic gastrostomy) · Adults receiving radiotherapy to the head and neck
Granulocyte-macrophage colony-stimulating factor (GM-CSF), mouthwash showed no clear difference in normalcy of diet (percutaneous endoscopic gastrostomy) compared with sucralfate mouthwash; GRADE not reported.
1 finding from 1 review
Normalcy of diet (percutaneous endoscopic gastrostomy) · Adults with cancer receiving treatment
Granulocyte-colony stimulating factor (G-CSF) showed no clear difference in normalcy of diet (percutaneous endoscopic gastrostomy) compared with placebo or no treatment; GRADE not reported.
1 finding from 1 review
Intervention not reported
Co‐amoxiclav or cefotaxime versus placebo (percutaneous endoscopic gastrostomy) · surgical patients
The intervention may leads to lower co‐amoxiclav or cefotaxime versus placebo (percutaneous endoscopic… (low certainty).
1 finding from 1 review
Intervention not reported
Co‐amoxiclav or cefotaxime versus placebo (percutaneous endoscopic gastrostomy) · surgical patients
It is very uncertain whether the intervention changes co‐amoxiclav or cefotaxime versus placebo (percutaneous endoscopic… (very low certainty).
1 finding from 1 review
Intervention not reported
Co‐amoxiclav or cefotaxime versus placebo (percutaneous endoscopic gastrostomy) · surgical patients
The intervention may leads to lower co‐amoxiclav or cefotaxime versus placebo (percutaneous endoscopic… (low certainty).
1 finding from 1 review